(Q52544620)

3 May 2018

title

Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. (English)

1 reference

3 May 2018

1 reference

1 reference

K Nishimura

1

1 reference

3 May 2018

N Nonomura

2

1 reference

3 May 2018

E Satoh

3

1 reference

3 May 2018

Y Harada

4

1 reference

3 May 2018

M Nakayama

5

1 reference

3 May 2018

T Tokizane

6

1 reference

3 May 2018

T Fukui

7

1 reference

3 May 2018

Y Ono

8

1 reference

3 May 2018

H Inoue

9

1 reference

3 May 2018

M Shin

10

1 reference

3 May 2018

Y Tsujimoto

11

1 reference

3 May 2018

H Takayama

12

1 reference

3 May 2018

K Aozasa

13

1 reference

3 May 2018

A Okuyama

14

1 reference

3 May 2018

language of work or name

English

0 references

publication date

1 November 2001

1 reference

3 May 2018

Journal of the National Cancer Institute

published in

1 reference

3 May 2018

volume

93

1 reference

3 May 2018

issue

22

1 reference

3 May 2018

page(s)

1739-1746

1 reference

3 May 2018

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Low doses of oral dexamethasone for hormone-refractory prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Glucocorticoids in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Homologous down-regulation of the glucocorticoid receptor down-modulates cellular hormone responsiveness in human histiocytic lymphoma U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Effect of 5-alpha-reductase inhibition and dexamethasone administration on the growth characteristics and intratumor androgen levels of the human prostate cancer cell line PC-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Cross-talk between glucocorticoid receptor and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

p57Kip2, a glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Aberrant rel/nfkb genes and activity in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F93.22.1739

21 January 2018

Identifiers

DOI

10.1093/JNCI/93.22.1739

1 reference

3 May 2018

1 reference

3 May 2018